Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Endometrial Neoplasms × dostarlimab × Clear all

Phase

Phase 2 7 Phase 1 3 Phase 1/2 2 Phase 4 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Medroxyprogesterone Acetate 2 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 fluciclovine F-18 1 dostarlimab 1 Watchful Waiting 1 Sunitinib 1 Specimen Handling 1 Observation 1 Metformin 1 LY 353381 1 Indocyanine Green 1 High-Energy Shock Waves 1 Biomarkers 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

GlaxoSmithKline

Phase 4 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡